Pre-market hot trades in US stocks: PAVmed up 9.96% in pre-market; NovaBay Pharmaceuticals down 7.26% in pre-market

Pre-market Hot Trades in US Stocks PAVmed is up 9.96% in pre-market trading. Based on recent news, On December 30, PAVmed announced a 1-for-30 reverse stock split. This move aims to bring the company in line with Nasdaq's minimum bid requirement of $1. The reverse split will take effect on January 2, 2026, reducing the authorized shares of common stock from 250 million to 25 million. Following this announcement, PAVmed's pre-market stock price rose by 9.96%. On December 30, PAVmed's key subsidiary Lucid Diagnostics launched the EsoGuard esophageal DNA test and EsoCheck esophageal cell collection device for the early detection of precancerous lesions in the esophagus. Additionally, Veris Health is developing remote patient monitoring solutions and implantable physiological monitors to support personalized cancer care. This news further boosted market confidence. On December 30, PAVmed listed new risks and uncertainties that its future operations may face in its latest annual report. Despite these risks, investors remain optimistic about the company's growth prospects. The reverse stock split and new product launches have bolstered market confidence. NovaBay Pharmaceuticals is down 7.26% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Top Gainers in Pre-market US Stocks Direct Digital is up 70.15% in pre-market trading. Based on recent key news: On December 29, analysts rated Direct Digital Holdings as hold, with a target price of $0.06. The company faces significant financial and operational challenges, and technical analysis shows a bearish trend, with increased risks of potential delisting. Despite strategic initiatives, financial difficulties dominate the outlook. Source: TipRanks On December 30, Direct Digital Holdings corrected errors in its previously submitted Form 8-K, updating the meeting date. This correction did not make any other changes to the original document. Source: EDGAR No other significant news recently. Market volatility is notable, and capital flow should be monitored. Anghami is up 47.41% in pre-market trading. Based on recent key news: On December 31, Anghami announced its financial report for the first half of 2025, with revenue growth of 97% to $48.4 million, primarily driven by an increase in subscription users. The stock price rose by 46.5% in after-hours trading. Source: WSJ On December 30, Anghami reached a transformative agreement with Warner Bros. Discovery to drive future growth for the company. Source: Reuters On December 31, despite a 71.84% drop in stock price over the past 12 months, the market remains cautiously optimistic about its long-term potential. Source: Benzinga The industry faces competitive pressure and needs to pay attention to policy changes. Northann, pre-market up 43.25%, has no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation